Literature DB >> 9443038

Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets.

T Akasaka1, H Akasaka, N Yonetani, H Ohno, H Yamabe, S Fukuhara, M Okuma.   

Abstract

The t(14;18)(q32;q21) translocation, involving the BCL2 gene and junctional segments (JH) of the immunoglobulin heavy chain gene (IGH), constitutes the most common chromosomal translocation in non-Hodgkin's lymphoma of B-cell type. Although the breakpoints in BCL2 are largely clustered within the major breakpoint region (MBR) and minor cluster region (mcr), it is known that some breakpoints map away from these regions, resulting in negative amplification of the junctional sequence by polymerase chain reaction (PCR) for < 1 kb targets. To circumvent this problem, we applied a novel PCR technology for long DNA targets, long-distance (LD-) PCR, to the detection of t(14;18) in clinical materials. Oligonucleotide primers were designed to be quite distant from the two known cluster regions in BCL2, and those for the corresponding IGH were complementary to the enhancer and constant regions. In all 52 cases identified as carrying BCL2/JH fusion by conventional Southern blot analysis, LD-PCR successfully amplified fragments encompassing the junctions, which were readily identifiable on ethidium bromide-stained gel. The size of the LD-PCR products ranged from 3.9 kb to 10.7 kb in MBR/IGH fusion and 1.9 kb to 16 kb in mcr/IGH fusion. Furthermore, we established an LD-PCR protocol for > 20 kb targets, which covered the intervening region between the MBR and mcr. Restriction analysis of the LD-PCR products revealed that breakpoints in 33 cases fell within the 150 bp-MBR region, and in 3 cases were within the mcr determined previously by others. In contrast, the breakpoints of the remaining 16 cases were distributed over a large region from the MBR through mcr. Nucleotide sequence analysis of a potential cluster region revealed the presence of an Alu repeat sequence. Restriction analysis of LD-PCR products with BstEII demonstrated a predominant usage of the JH6 segment (71%) at the BCL2/JH junctions. LD-PCR using primers for the constant region genes showed that class switch recombination occurred in more than 80% of the IGH genes on the der(14) chromosome. Our study showed that LD-PCR was capable of detecting virtually any t(14;18) that occurred within the approximately 30 kb region downstream of the MBR, and thus is suitable for initial diagnosis of lymphoma tissues. Furthermore, as amplified fragments obtained by the LD-PCR contained distinctive regions of BCL2 and IGH, restriction analysis and nucleotide sequencing of the products refined the characteristics of t(14;18).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443038     DOI: 10.1002/(sici)1098-2264(199801)21:1<17::aid-gcc4>3.0.co;2-b

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

Review 1.  Detection of BCL2 rearrangements in follicular lymphoma.

Authors:  Jon C Aster; Janina A Longtine
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction.

Authors:  Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; Roger G Owen; Gareth J Morgan; Andrew S Jack
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

3.  Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.

Authors:  Chiyoko Ueda; Momoko Nishikori; Toshio Kitawaki; Takashi Uchiyama; Hitoshi Ohno
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

4.  Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR.

Authors:  P J Batstone; J R Goodlad
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

5.  Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction.

Authors:  Nancy Pennell; Anthony Woods; Marciano Reis; Rena Buckstein; David Spaner; Kevin Imrie; Karen Hewitt; Angela Boudreau; Arun Seth; Neil L Berinstein
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

6.  Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.

Authors:  Janice M Spence; Paul G Rothberg; Nancy Wang; W Richard Burack
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

Review 7.  Gastrointestinal follicular lymphoma: review of the literature.

Authors:  Shuji Yamamoto; Hiroshi Nakase; Kouhei Yamashita; Minoru Matsuura; Mariko Takada; Chiharu Kawanami; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

Review 8.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

Review 9.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

10.  ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.

Authors:  Olga K Weinberg; Weiyun Z Ai; M Rajan Mariappan; Carol Shum; Ronald Levy; Daniel A Arber
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.